Robert Boileau

724 total citations
22 papers, 562 citations indexed

About

Robert Boileau is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Robert Boileau has authored 22 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 6 papers in Physiology and 3 papers in Epidemiology. Recurrent topics in Robert Boileau's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Occupational and environmental lung diseases (7 papers) and Asthma and respiratory diseases (5 papers). Robert Boileau is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Occupational and environmental lung diseases (7 papers) and Asthma and respiratory diseases (5 papers). Robert Boileau collaborates with scholars based in Canada and France. Robert Boileau's co-authors include R. Bégin, André M. Cantin, S. Massé, Guy Bisson, Marek Rola‐Pleszczynski, G. Drapeau, Yves Berthiaume, Richard R. Martin, Marc Martel and Charles G. Irvin and has published in prestigious journals such as Science, Gastroenterology and CHEST Journal.

In The Last Decade

Robert Boileau

22 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Boileau Canada 12 388 97 80 69 60 22 562
Toshihide Hayano Japan 11 208 0.5× 39 0.4× 55 0.7× 57 0.8× 22 0.4× 20 457
Dóra Lúðvíksdóttir Sweden 16 450 1.2× 39 0.4× 588 7.3× 37 0.5× 35 0.6× 22 798
R Roméo Italy 9 60 0.2× 15 0.2× 46 0.6× 26 0.4× 13 0.2× 28 373
Junichi Narita Japan 12 111 0.3× 93 1.0× 31 0.4× 23 0.3× 12 0.2× 34 516
J. Groh Germany 11 117 0.3× 16 0.2× 44 0.6× 43 0.6× 6 0.1× 31 408
Gary Stapleton United States 11 175 0.5× 16 0.2× 23 0.3× 141 2.0× 15 0.3× 44 670
Jelte de Haan Netherlands 12 117 0.3× 53 0.5× 13 0.2× 59 0.9× 18 0.3× 25 519
Hilmi Apak Türkiye 14 33 0.1× 94 1.0× 45 0.6× 57 0.8× 9 0.1× 44 445
Fotios Drakopanagiotakis Greece 11 422 1.1× 54 0.6× 154 1.9× 84 1.2× 10 0.2× 33 587
B. Cramer Canada 13 242 0.6× 60 0.6× 36 0.5× 33 0.5× 2 0.0× 33 1.5k

Countries citing papers authored by Robert Boileau

Since Specialization
Citations

This map shows the geographic impact of Robert Boileau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Boileau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Boileau more than expected).

Fields of papers citing papers by Robert Boileau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Boileau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Boileau. The network helps show where Robert Boileau may publish in the future.

Co-authorship network of co-authors of Robert Boileau

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Boileau. A scholar is included among the top collaborators of Robert Boileau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Boileau. Robert Boileau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boileau, Robert, et al.. (2015). Mediastinal Abscess Following Endobronchial Ultrasound Transbronchial Needle Aspiration in a Patient With Sarcoidosis. Journal of Bronchology & Interventional Pulmonology. 22(4). 370–372. 8 indexed citations
2.
Beauchesne, Marie-France, et al.. (2013). Appropriateness of Triple Therapy after COPD Exacerbation. The Canadian Journal of Hospital Pharmacy. 66(1). 41–2. 1 indexed citations
3.
Beauchesne, Marie-France, et al.. (2012). Community Pharmacy—Based Medication Assessment Program for Asthma and Chronic Obstructive Pulmonary Disease. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 145(2). 70–71. 8 indexed citations
4.
Blais, Lucie, et al.. (2012). Management of Chronic Obstructive Pulmonary Disease in Patients Admitted to a Tertiary Care Centre for Exacerbation of Their Disease. The Canadian Journal of Hospital Pharmacy. 65(5). 373–9. 5 indexed citations
5.
Huet, Pierre–Michel, Catherine Vincent, Jean Côté, et al.. (2009). Portal hypertension in primary biliary cirrhosis (PBC): A reversible condition? Yes, but not in all UDCA treated patients. Hepatology Research. 39(10). 1032–1038. 5 indexed citations
6.
Huet, Pierre–Michel, et al.. (2008). Portal Hypertension and Primary Biliary Cirrhosis: Effect of Long-Term Ursodeoxycholic Acid Treatment. Gastroenterology. 135(5). 1552–1560. 54 indexed citations
7.
Prévost, Sylvain, Luc Boucher, Pierre Larivée, Robert Boileau, & François Bénard. (2006). Bone marrow hypermetabolism on 18F-FDG PET as a survival prognostic factor in non-small cell lung cancer.. PubMed. 47(4). 559–65. 49 indexed citations
8.
Verreault, Jean, et al.. (2001). Extensive F-18 FDG Uptake in Metastatic Spindle Cell Carcinoma of the Lung. Clinical Nuclear Medicine. 26(1). 79–80. 2 indexed citations
9.
Cantin, André M., Robert Boileau, & R. Bégin. (1988). Increased Procollagen III Aminoterminal Peptide-related Antigens and Fibroblast Growth Signals in the Lungs of Patients with Idiopathic Pulmonary Fibrosis. American Review of Respiratory Disease. 137(3). 572–578. 54 indexed citations
10.
Boileau, Robert, et al.. (1988). Cyclic nucleotides of lung lavage following acute antigen exposure in chronically exposed sheep. Inflammation. 12(3). 245–250. 3 indexed citations
11.
Bégin, R., André M. Cantin, Robert Boileau, & Guy Bisson. (1987). Spectrum of Alveolitis in Quartz-Exposed Human Subjects. CHEST Journal. 92(6). 1061–1067. 38 indexed citations
12.
Bégin, R., et al.. (1987). Asbestos exposure, cigarette smoking, and airflow limitation in long‐term canadian chrysotile miners and millers. American Journal of Industrial Medicine. 11(1). 55–66. 31 indexed citations
13.
Boileau, Robert, et al.. (1987). Chronic allergic airway disease in the sheep model: Functional and lung-lavage features. Journal of Allergy and Clinical Immunology. 79(2). 339–344. 14 indexed citations
14.
Bégin, R., et al.. (1986). Elevated histamine content of lung lavage in human asbestosis. Lung. 164(1). 199–205. 2 indexed citations
15.
Bégin, R., Marc Martel, G. Drapeau, et al.. (1986). Fibronectin and Procollagen 3 Levels in Bronchoalveolar Lavage of Asbestos-Exposed Human Subjects and Sheep. CHEST Journal. 89(2). 237–243. 66 indexed citations
16.
Bégin, R., et al.. (1986). Enzyme activities of lung lavage in asbestosis. Clinical Biochemistry. 19(4). 240–243. 7 indexed citations
17.
Cantin, André M., R. Bégin, Robert Boileau, G. Drapeau, & Marek Rola‐Pleszczynski. (1984). Features of bronchoalveolar lavage differentiating hypersensitivity pneumonitis and pulmonary sarcoidosis at time of initial presentation.. PubMed. 7(2). 89–94. 8 indexed citations
18.
Cantin, André M., R. Bégin, Marek Rola‐Pleszczynski, & Robert Boileau. (1983). Heterogeneity of Bronchoalveolar Lavage Cellularity in Stage III Pulmonary Sarcoidosis. CHEST Journal. 83(3). 485–486. 22 indexed citations
19.
Bégin, R., et al.. (1983). Airway function in lifetime-nonsmoking older asbestos workers. The American Journal of Medicine. 75(4). 631–638. 54 indexed citations
20.
Irvin, Charles G., Robert Boileau, Jacques Tremblay, Richard R. Martin, & Peter T. Macklem. (1980). Bronchodilatation: Noncholinergic, Nonadrenergic Mediation Demonstrated in Vivo in the Cat. Science. 207(4432). 791–792. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshihide Hayano Breakdown of academic impact, for papers by Dóra Lúðvíksdóttir Breakdown of academic impact, for papers by R Roméo Breakdown of academic impact, for papers by Junichi Narita Breakdown of academic impact, for papers by J. Groh Breakdown of academic impact, for papers by Gary Stapleton Breakdown of academic impact, for papers by Jelte de Haan Breakdown of academic impact, for papers by Hilmi Apak Breakdown of academic impact, for papers by Fotios Drakopanagiotakis Breakdown of academic impact, for papers by B. Cramer
Rankless by CCL
2026